Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Novartis AG (0QLR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
83.83 +0.33    +0.40%
17:57:05 - Closed. Currency in CHF ( Disclaimer )
  • Volume: 295,173
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 83.83 - 83.83
Type:  Equity
Market:  United Kingdom
ISIN:  CH0012005267 
SEDOL:  B10S3M3
Novartis 83.83 +0.33 +0.40%

0QLR Recent Sentiments

 
This page features our users' sentiments regarding the Novartis share. Assess users' predictions on whether they expect Novartis shares to be bearish or bullish.
Start Date Username Call Open Rate End Date Chg. %
Oct 31, 2022 Cac Trader   80.33 Nov 07, 2022 @ 80.65 +0.40%
May 09, 2022 Anita Vacca   84.24 May 12, 2022 @ 83.38 +1.02%
Mar 08, 2022 Rumen Makaveev   74.68 Mar 14, 2022 @ 78.75 +5.45%
Feb 02, 2022 Anton de Boer   78.63 Feb 25, 2022 @ 80.00 +1.74%
Nov 26, 2021 Sebastiaan Seghers   74.94 Nov 29, 2021 @ 74.25 -0.92%
Jan 18, 2021 Victor Chu   84.35 Feb 12, 2021 @ 81.86 -2.95%
Mar 20, 2020 trade vostok   77.99 Apr 01, 2020 @ 79.66 +2.14%
Mar 12, 2020 Fabi Borba   74.42 Apr 03, 2020 @ 81.80 +9.92%
Feb 28, 2020 Annmarie Cassar   82.26 Mar 03, 2020 @ 81.07 -1.45%
Feb 11, 2020 Mehran Nazmi   95.54 Mar 06, 2020 @ 79.18 -17.12%
Aug 30, 2019 iain mackenzie   89.68 Sep 20, 2019 @ 86.26 -3.81%
May 15, 2019 Fabián Escoí   81.31 May 15, 2019 @ 81.33 -0.02%
May 07, 2019 KUMARJIT DAS   83.70 May 31, 2019 @ 86.10 +2.87%
Apr 01, 2019 Shadab Reshi   95.63 Apr 26, 2019 @ 82.63 -13.59%
Sep 21, 2018 Eni Ayi   81.54 Oct 21, 2018 @ 5565.06 +6724.94%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lee Taylor
Lee Taylor Dec 01, 2021 10:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …
Lukas Bednall
Lukas Bednall Sep 28, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email